SGS Facilitates Selecta Biosciences and AskBio’s FIH Study to Evaluate ImmTOR™ in Gene Therapy
SGS is pleased to announce the support of Selecta Biosciences and Asklepios BioPharmaceutical, Inc. (AskBio) Phase 1 dose-escalation trial of SEL-399, an adeno-...





